Cargando…
Chronic lymphocytic leukemia: molecular heterogeneity revealed by high-throughput genomics
Chronic lymphocytic leukemia (CLL) has been consistently at the forefront of genetic research owing to its prevalence and the accessibility of sample material. Recently, genome-wide technologies have been intensively applied to CLL genetics, with remarkable progress. Single nucleotide polymorphism a...
Autores principales: | Landau, Dan A, Wu, Catherine J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706960/ https://www.ncbi.nlm.nih.gov/pubmed/23731665 http://dx.doi.org/10.1186/gm451 |
Ejemplares similares
-
Clinical and Biological Relevance of Genomic Heterogeneity in Chronic Lymphocytic Leukemia
por: Friedman, Daphne R., et al.
Publicado: (2013) -
Druggable Molecular Pathways in Chronic Lymphocytic Leukemia
por: Almasri, Mohammad, et al.
Publicado: (2022) -
The immune microenvironment shapes transcriptional and genetic heterogeneity in chronic lymphocytic leukemia
por: Sun, Clare, et al.
Publicado: (2022) -
A novel ex vivo high-throughput assay reveals antiproliferative effects of idelalisib and ibrutinib in chronic lymphocytic leukemia
por: Primo, Daniel, et al.
Publicado: (2018) -
The genomic landscape of chronic lymphocytic leukemia: clinical implications
por: Quesada, Víctor, et al.
Publicado: (2013)